7-bromo-2-[3-(5-fluoro-6-methyl-2-pyridinyl)-1-(oxan-2-yl)pyrazol-4-yl]-1,5-naphthyridine;7-bromo-2-[5-(5-fluoro-6-methyl-2-pyridinyl)-1-(oxan-2-yl)pyrazol-4-yl]-1,5-naphthyridine;2-(2,2-dimethylpyrrolidin-1-yl)ethanamine;7-[3-(2,2-dimethylpyrrolidin-1-yl)propyl]-2-[5-(5-fluoro-6-methyl-2-pyridinyl)-1H-pyrazol-4-yl]-1,5-naphthyridine

C78H85Br2F3N18O2 — CID 159821311

IUPAC7-bromo-2-[3-(5-fluoro-6-methyl-2-pyridinyl)-1-(oxan-2-yl)pyrazol-4-yl]-1,5-naphthyridine;7-bromo-2-[5-(5-fluoro-6-methyl-2-pyridinyl)-1-(oxan-2-yl)pyrazol-4-yl]-1,5-naphthyridine;2-(2,2-dimethylpyrrolidin-1-yl)ethanamine;7-[3-(2,2-dimethylpyrrolidin-1-yl)propyl]-2-[5-(5-fluoro-6-methyl-2-pyridinyl)-1H-pyrazol-4-yl]-1,5-naphthyridine
SMILESCC1(C)CCCN1CCN.Cc1nc(-c2[nH]ncc2-c2ccc3ncc(CCCN4CCCC4(C)C)cc3n2)ccc1F.Cc1nc(-c2c(-c3ccc4ncc(Br)cc4n3)cnn2C2CCCCO2)ccc1F.Cc1nc(-c2nn(C3CCCCO3)cc2-c2ccc3ncc(Br)cc3n2)ccc1F
InChIInChI=1S/C26H29FN6.2C22H19BrFN5O.C8H18N2/c1-17-20(27)7-8-23(30-17)25-19(16-29-32-25)21-9-10-22-24(31-21)14-18(15-28-22)6-4-12-33-13-5-11-26(33,2)3;1-13-16(24)5-6-19(26-13)22-15(12-29(28-22)21-4-2-3-9-30-21)17-7-8-18-20(27-17)10-14(23)11-25-18;1-13-16(24)5-6-19(27-13)22-15(12-26-29(22)21-4-2-3-9-30-21)17-7-8-18-20(28-17)10-14(23)11-25-18;1-8(2)4-3-6-10(8)7-5-9/h7-10,14-16H,4-6,11-13H2,1-3H3,(H,29,32);2*5-8,10-12,21H,2-4,9H2,1H3;3-7,9H2,1-2H3
InChIKeyNMGSZTRBNVXHHV-UHFFFAOYSA-N
MW1523.46 g/mol
LogP17.08
Rot. Bonds14

About 7-bromo-2-[3-(5-fluoro-6-methyl-2-pyridinyl)-1-(oxan-2-yl)pyrazol-4-yl]-1,5-naphthyridine;7-bromo-2-[5-(5-fluoro-6-methyl-2-pyridinyl)-1-(oxan-2-yl)pyrazol-4-yl]-1,5-naphthyridine;2-(2,2-dimethylpyrrolidin-1-yl)ethanamine;7-[3-(2,2-dimethylpyrrolidin-1-yl)propyl]-2-[5-(5-fluoro-6-methyl-2-pyridinyl)-1H-pyrazol-4-yl]-1,5-naphthyridine

7-bromo-2-[3-(5-fluoro-6-methyl-2-pyridinyl)-1-(oxan-2-yl)pyrazol-4-yl]-1,5-naphthyridine;7-bromo-2-[5-(5-fluoro-6-methyl-2-pyridinyl)-1-(oxan-2-yl)pyrazol-4-yl]-1,5-naphthyridine;2-(2,2-dimethylpyrrolidin-1-yl)ethanamine;7-[3-(2,2-dimethylpyrrolidin-1-yl)propyl]-2-[5-(5-fluoro-6-methyl-2-pyridinyl)-1H-pyrazol-4-yl]-1,5-naphthyridine (PubChem CID 159821311) has the molecular formula C78H85Br2F3N18O2 and a molecular weight of 1523.46 g/mol. Its IUPAC name is 7-bromo-2-[3-(5-fluoro-6-methyl-2-pyridinyl)-1-(oxan-2-yl)pyrazol-4-yl]-1,5-naphthyridine;7-bromo-2-[5-(5-fluoro-6-methyl-2-pyridinyl)-1-(oxan-2-yl)pyrazol-4-yl]-1,5-naphthyridine;2-(2,2-dimethylpyrrolidin-1-yl)ethanamine;7-[3-(2,2-dimethylpyrrolidin-1-yl)propyl]-2-[5-(5-fluoro-6-methyl-2-pyridinyl)-1H-pyrazol-4-yl]-1,5-naphthyridine.

Molecular Properties

Compound Name7-bromo-2-[3-(5-fluoro-6-methyl-2-pyridinyl)-1-(oxan-2-yl)pyrazol-4-yl]-1,5-naphthyridine;7-bromo-2-[5-(5-fluoro-6-methyl-2-pyridinyl)-1-(oxan-2-yl)pyrazol-4-yl]-1,5-naphthyridine;2-(2,2-dimethylpyrrolidin-1-yl)ethanamine;7-[3-(2,2-dimethylpyrrolidin-1-yl)propyl]-2-[5-(5-fluoro-6-methyl-2-pyridinyl)-1H-pyrazol-4-yl]-1,5-naphthyridine
PubChem CID159821311
Molecular FormulaC78H85Br2F3N18O2
Molecular Weight1523.46 g/mol
Exact Mass1520.54
IUPAC Name7-bromo-2-[3-(5-fluoro-6-methyl-2-pyridinyl)-1-(oxan-2-yl)pyrazol-4-yl]-1,5-naphthyridine;7-bromo-2-[5-(5-fluoro-6-methyl-2-pyridinyl)-1-(oxan-2-yl)pyrazol-4-yl]-1,5-naphthyridine;2-(2,2-dimethylpyrrolidin-1-yl)ethanamine;7-[3-(2,2-dimethylpyrrolidin-1-yl)propyl]-2-[5-(5-fluoro-6-methyl-2-pyridinyl)-1H-pyrazol-4-yl]-1,5-naphthyridine
SMILESCC1(C)CCCN1CCN.Cc1nc(-c2[nH]ncc2-c2ccc3ncc(CCCN4CCCC4(C)C)cc3n2)ccc1F.Cc1nc(-c2c(-c3ccc4ncc(Br)cc4n3)cnn2C2CCCCO2)ccc1F.Cc1nc(-c2nn(C3CCCCO3)cc2-c2ccc3ncc(Br)cc3n2)ccc1F
InChIInChI=1S/C26H29FN6.2C22H19BrFN5O.C8H18N2/c1-17-20(27)7-8-23(30-17)25-19(16-29-32-25)21-9-10-22-24(31-21)14-18(15-28-22)6-4-12-33-13-5-11-26(33,2)3;1-13-16(24)5-6-19(26-13)22-15(12-29(28-22)21-4-2-3-9-30-21)17-7-8-18-20(27-17)10-14(23)11-25-18;1-13-16(24)5-6-19(27-13)22-15(12-26-29(22)21-4-2-3-9-30-21)17-7-8-18-20(28-17)10-14(23)11-25-18;1-8(2)4-3-6-10(8)7-5-9/h7-10,14-16H,4-6,11-13H2,1-3H3,(H,29,32);2*5-8,10-12,21H,2-4,9H2,1H3;3-7,9H2,1-2H3
InChIKeyNMGSZTRBNVXHHV-UHFFFAOYSA-N
XLogP17.08
TPSA231.29 Ų
H-Bond Donors2
H-Bond Acceptors19
Rotatable Bonds14
Heavy Atoms103
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001523.46
LogP ≤ 517.08
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1019

Analyze 7-bromo-2-[3-(5-fluoro-6-methyl-2-pyridinyl)-1-(oxan-2-yl)pyrazol-4-yl]-1,5-naphthyridine;7-bromo-2-[5-(5-fluoro-6-methyl-2-pyridinyl)-1-(oxan-2-yl)pyrazol-4-yl]-1,5-naphthyridine;2-(2,2-dimethylpyrrolidin-1-yl)ethanamine;7-[3-(2,2-dimethylpyrrolidin-1-yl)propyl]-2-[5-(5-fluoro-6-methyl-2-pyridinyl)-1H-pyrazol-4-yl]-1,5-naphthyridine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 7-bromo-2-[3-(5-fluoro-6-methyl-2-pyridinyl)-1-(oxan-2-yl)pyrazol-4-yl]-1,5-naphthyridine;7-bromo-2-[5-(5-fluoro-6-methyl-2-pyridinyl)-1-(oxan-2-yl)pyrazol-4-yl]-1,5-naphthyridine;2-(2,2-dimethylpyrrolidin-1-yl)ethanamine;7-[3-(2,2-dimethylpyrrolidin-1-yl)propyl]-2-[5-(5-fluoro-6-methyl-2-pyridinyl)-1H-pyrazol-4-yl]-1,5-naphthyridine?
The IUPAC name of 7-bromo-2-[3-(5-fluoro-6-methyl-2-pyridinyl)-1-(oxan-2-yl)pyrazol-4-yl]-1,5-naphthyridine;7-bromo-2-[5-(5-fluoro-6-methyl-2-pyridinyl)-1-(oxan-2-yl)pyrazol-4-yl]-1,5-naphthyridine;2-(2,2-dimethylpyrrolidin-1-yl)ethanamine;7-[3-(2,2-dimethylpyrrolidin-1-yl)propyl]-2-[5-(5-fluoro-6-methyl-2-pyridinyl)-1H-pyrazol-4-yl]-1,5-naphthyridine (CID 159821311) is 7-bromo-2-[3-(5-fluoro-6-methyl-2-pyridinyl)-1-(oxan-2-yl)pyrazol-4-yl]-1,5-naphthyridine;7-bromo-2-[5-(5-fluoro-6-methyl-2-pyridinyl)-1-(oxan-2-yl)pyrazol-4-yl]-1,5-naphthyridine;2-(2,2-dimethylpyrrolidin-1-yl)ethanamine;7-[3-(2,2-dimethylpyrrolidin-1-yl)propyl]-2-[5-(5-fluoro-6-methyl-2-pyridinyl)-1H-pyrazol-4-yl]-1,5-naphthyridine.
What is the SMILES notation for 7-bromo-2-[3-(5-fluoro-6-methyl-2-pyridinyl)-1-(oxan-2-yl)pyrazol-4-yl]-1,5-naphthyridine;7-bromo-2-[5-(5-fluoro-6-methyl-2-pyridinyl)-1-(oxan-2-yl)pyrazol-4-yl]-1,5-naphthyridine;2-(2,2-dimethylpyrrolidin-1-yl)ethanamine;7-[3-(2,2-dimethylpyrrolidin-1-yl)propyl]-2-[5-(5-fluoro-6-methyl-2-pyridinyl)-1H-pyrazol-4-yl]-1,5-naphthyridine?
The canonical SMILES for 7-bromo-2-[3-(5-fluoro-6-methyl-2-pyridinyl)-1-(oxan-2-yl)pyrazol-4-yl]-1,5-naphthyridine;7-bromo-2-[5-(5-fluoro-6-methyl-2-pyridinyl)-1-(oxan-2-yl)pyrazol-4-yl]-1,5-naphthyridine;2-(2,2-dimethylpyrrolidin-1-yl)ethanamine;7-[3-(2,2-dimethylpyrrolidin-1-yl)propyl]-2-[5-(5-fluoro-6-methyl-2-pyridinyl)-1H-pyrazol-4-yl]-1,5-naphthyridine is CC1(C)CCCN1CCN.Cc1nc(-c2[nH]ncc2-c2ccc3ncc(CCCN4CCCC4(C)C)cc3n2)ccc1F.Cc1nc(-c2c(-c3ccc4ncc(Br)cc4n3)cnn2C2CCCCO2)ccc1F.Cc1nc(-c2nn(C3CCCCO3)cc2-c2ccc3ncc(Br)cc3n2)ccc1F.
What is the InChIKey of 7-bromo-2-[3-(5-fluoro-6-methyl-2-pyridinyl)-1-(oxan-2-yl)pyrazol-4-yl]-1,5-naphthyridine;7-bromo-2-[5-(5-fluoro-6-methyl-2-pyridinyl)-1-(oxan-2-yl)pyrazol-4-yl]-1,5-naphthyridine;2-(2,2-dimethylpyrrolidin-1-yl)ethanamine;7-[3-(2,2-dimethylpyrrolidin-1-yl)propyl]-2-[5-(5-fluoro-6-methyl-2-pyridinyl)-1H-pyrazol-4-yl]-1,5-naphthyridine?
The InChIKey is NMGSZTRBNVXHHV-UHFFFAOYSA-N. The full InChI is InChI=1S/C26H29FN6.2C22H19BrFN5O.C8H18N2/c1-17-20(27)7-8-23(30-17)25-19(16-29-32-25)21-9-10-22-24(31-21)14-18(15-28-22)6-4-12-33-13-5-11-26(33,2)3;1-13-16(24)5-6-19(26-13)22-15(12-29(28-22)21-4-2-3-9-30-21)17-7-8-18-20(27-17)10-14(23)11-25-18;1-13-16(24)5-6-19(27-13)22-15(12-26-29(22)21-4-2-3-9-30-21)17-7-8-18-20(28-17)10-14(23)11-25-18;1-8(2)4-3-6-10(8)7-5-9/h7-10,14-16H,4-6,11-13H2,1-3H3,(H,29,32);2*5-8,10-12,21H,2-4,9H2,1H3;3-7,9H2,1-2H3.
What are the key properties of 7-bromo-2-[3-(5-fluoro-6-methyl-2-pyridinyl)-1-(oxan-2-yl)pyrazol-4-yl]-1,5-naphthyridine;7-bromo-2-[5-(5-fluoro-6-methyl-2-pyridinyl)-1-(oxan-2-yl)pyrazol-4-yl]-1,5-naphthyridine;2-(2,2-dimethylpyrrolidin-1-yl)ethanamine;7-[3-(2,2-dimethylpyrrolidin-1-yl)propyl]-2-[5-(5-fluoro-6-methyl-2-pyridinyl)-1H-pyrazol-4-yl]-1,5-naphthyridine?
7-bromo-2-[3-(5-fluoro-6-methyl-2-pyridinyl)-1-(oxan-2-yl)pyrazol-4-yl]-1,5-naphthyridine;7-bromo-2-[5-(5-fluoro-6-methyl-2-pyridinyl)-1-(oxan-2-yl)pyrazol-4-yl]-1,5-naphthyridine;2-(2,2-dimethylpyrrolidin-1-yl)ethanamine;7-[3-(2,2-dimethylpyrrolidin-1-yl)propyl]-2-[5-(5-fluoro-6-methyl-2-pyridinyl)-1H-pyrazol-4-yl]-1,5-naphthyridine has a molecular weight of 1523.46 g/mol, XLogP of 17.08, 14 rotatable bonds, 2 hydrogen bond donors, and 19 hydrogen bond acceptors.
Where does this data come from?
All data for 7-bromo-2-[3-(5-fluoro-6-methyl-2-pyridinyl)-1-(oxan-2-yl)pyrazol-4-yl]-1,5-naphthyridine;7-bromo-2-[5-(5-fluoro-6-methyl-2-pyridinyl)-1-(oxan-2-yl)pyrazol-4-yl]-1,5-naphthyridine;2-(2,2-dimethylpyrrolidin-1-yl)ethanamine;7-[3-(2,2-dimethylpyrrolidin-1-yl)propyl]-2-[5-(5-fluoro-6-methyl-2-pyridinyl)-1H-pyrazol-4-yl]-1,5-naphthyridine is sourced from PubChem (CID 159821311), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).